Gérard Barthélémy

Author

Gérard Barthélémy

Also Known As

G Barthelemy, G Barthélémy, G. Barthelemy, G. Barthélemy, Gérard Barthélémy

Publications

858

Citations

H-Index

Concepts

All Affiliations

Gérard Barthélémy is an author at Sanofi (France) specializing in medicine, pharmacology, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	608
2	Public Health	1	1	16
3	Epidemiology	1	1	556
4	Microbiology	1	1	556
5	Obstetrics	1	1	16

Gérard Barthélémy

Publications

847

Citations

H-Index

Page 1

	Year	Citations
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq, The Lancet Infectious Diseases Prognostic FactorsFoodborne IllnessClinical FeaturesMicrobiologyInfection Control	2017	556
Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist. Catherine Cazaubon, Jean Gougat, F Bousquet, Journal of Pharmacology and Experimental Therapeutics	1993	189
Differential Sensitivity to Cardiotonic Drugs of Cyclic AMP Phosphodiesterases Isolated from Canine Ventricular and Sinoatrial-Enriched Tissues Narcisse Komas, Claire Lugnier, Alain Le Bec, Journal of Cardiovascular Pharmacology	1989	50
Antithrombotic Activity of SR 46349, a Novel, Potent and Selective 5-HT2 Receptor Antagonist Jean‐Marc Herbert, A. Bernat, Gérard Barthélémy, Thrombosis and Haemostasis ThrombopoiesisThrombosisMedicinal ChemistryBlood PlateletMedicine	1993	21
P-008. Decline in sperm quality of fertile men in the centre of France S. Hamamah, Gérard Barthélémy, Bette Hubert, Human Reproduction InfertilityAndrologyMale FertilityFertilitySperm Quality	1997	16
SR 48692, a non-peptide neurotensin receptor antagonist, blocks the cardiovascular effects elicited by neurotensin in guinea pigs Dino Nisato, Pierre Guiraudou, Gérard Barthélémy, Life Sciences Molecular PharmacologyHypertensionCardiovascular DiseaseSr 48692Guinea Pigs	1994	15

Page 1